These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17692438)

  • 21. A meta-analysis of intradermal versus intramuscular influenza vaccines: immunogenicity and adverse events.
    Marra F; Young F; Richardson K; Marra CA
    Influenza Other Respir Viruses; 2013 Jul; 7(4):584-603. PubMed ID: 22974174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum antibody responses after intradermal vaccination against influenza.
    Belshe RB; Newman FK; Cannon J; Duane C; Treanor J; Van Hoecke C; Howe BJ; Dubin G
    N Engl J Med; 2004 Nov; 351(22):2286-94. PubMed ID: 15525713
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunogenicity of intradermal influenza vaccination in COPD patients.
    Chuaychoo B; Wongsurakiat P; Nana A; Kositanont U; Maranetra KN
    Vaccine; 2010 May; 28(24):4045-51. PubMed ID: 20412877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody responses after dose-sparing intradermal influenza vaccination.
    Auewarakul P; Kositanont U; Sornsathapornkul P; Tothong P; Kanyok R; Thongcharoen P
    Vaccine; 2007 Jan; 25(4):659-63. PubMed ID: 17011678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancing Immunogenicity of Influenza Vaccine in the Elderly through Intradermal Vaccination: A Literature Analysis.
    Quach HQ; Kennedy RB
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36366536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of a quadrivalent intradermal influenza vaccine in adults.
    Gorse GJ; Falsey AR; Ozol-Godfrey A; Landolfi V; Tsang PH
    Vaccine; 2015 Feb; 33(9):1151-9. PubMed ID: 25613721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity and safety of intradermal influenza vaccine in children.
    Esposito S; Daleno C; Picciolli I; Tagliaferri L; Scala A; Prunotto G; Montinaro V; Galeone C; Principi N
    Vaccine; 2011 Oct; 29(44):7606-10. PubMed ID: 21855592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.
    Arnou R; Icardi G; De Decker M; Ambrozaitis A; Kazek MP; Weber F; Van Damme P
    Vaccine; 2009 Dec; 27(52):7304-12. PubMed ID: 19849996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.
    Treanor JJ; Schiff GM; Couch RB; Cate TR; Brady RC; Hay CM; Wolff M; She D; Cox MM
    J Infect Dis; 2006 May; 193(9):1223-8. PubMed ID: 16586358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose sparing intradermal trivalent influenza (2010/2011) vaccination overcomes reduced immunogenicity of the 2009 H1N1 strain.
    Hung IF; Levin Y; To KK; Chan KH; Zhang AJ; Li P; Li C; Xu T; Wong TY; Yuen KY
    Vaccine; 2012 Oct; 30(45):6427-35. PubMed ID: 22910287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.
    Combadière B; Vogt A; Mahé B; Costagliola D; Hadam S; Bonduelle O; Sterry W; Staszewski S; Schaefer H; van der Werf S; Katlama C; Autran B; Blume-Peytavi U
    PLoS One; 2010 May; 5(5):e10818. PubMed ID: 20520820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intradermal fractional booster dose of inactivated poliomyelitis vaccine with a jet injector in healthy adults.
    Soonawala D; Verdijk P; Wijmenga-Monsuur AJ; Boog CJ; Koedam P; Visser LG; Rots NY
    Vaccine; 2013 Aug; 31(36):3688-94. PubMed ID: 23770332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses.
    Ansaldi F; Canepa P; Ceravolo A; Valle L; de Florentiis D; Oomen R; Vogel FR; Denis M; Samson SI; Icardi G
    Vaccine; 2012 Apr; 30(18):2908-13. PubMed ID: 22342501
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical evaluation of a novel microneedle device for intradermal delivery of an influenza vaccine: are all delivery methods the same?
    Levin Y; Kochba E; Kenney R
    Vaccine; 2014 Jul; 32(34):4249-52. PubMed ID: 24930715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seasonal influenza vaccine delivered by intradermal microinjection: A randomised controlled safety and immunogenicity trial in adults.
    Leroux-Roels I; Vets E; Freese R; Seiberling M; Weber F; Salamand C; Leroux-Roels G
    Vaccine; 2008 Dec; 26(51):6614-9. PubMed ID: 18930093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventional influenza vaccination.
    Morelon E; Pouteil Noble C; Daoud S; Cahen R; Goujon-Henry C; Weber F; Laurent PE; Kaiserlian D; Nicolas JF
    Vaccine; 2010 Oct; 28(42):6885-90. PubMed ID: 20709000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Superior antibody and membrane protein-specific T-cell responses to CoronaVac by intradermal versus intramuscular routes in adolescents.
    Rosa Duque JS; Cheng SMS; Cohen CA; Leung D; Wang X; Mu X; Chung Y; Lau TM; Wang M; Zhang W; Zhang Y; Wong HHW; Tsang LCH; Chaothai S; Kwan TC; Li JKC; Chan KCK; Luk LLH; Ho JCH; Li WY; Lee AMT; Lam JHY; Chan SM; Wong WHS; Tam IYS; Mori M; Valkenburg SA; Peiris M; Tu W; Lau YL
    World J Pediatr; 2024 Apr; 20(4):353-370. PubMed ID: 38085470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intradermal versus intramuscular hepatitis B vaccination in hemodialysis patients: a prospective open-label randomized controlled trial in nonresponders to primary vaccination.
    Barraclough KA; Wiggins KJ; Hawley CM; van Eps CL; Mudge DW; Johnson DW; Whitby M; Carpenter S; Playford EG
    Am J Kidney Dis; 2009 Jul; 54(1):95-103. PubMed ID: 19481320
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superior immunogenicity profile of the new intradermal influenza vaccine compared to the standard subcutaneous vaccine in subjects 65 years and older: A randomized controlled phase III study.
    Arakane R; Annaka R; Takahama A; Ishida K; Yoshiike M; Nakayama T; Takeshita F
    Vaccine; 2015 Nov; 33(48):6650-8. PubMed ID: 26519549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children.
    Chiu SS; Peiris JS; Chan KH; Wong WH; Lau YL
    Pediatrics; 2007 Jun; 119(6):1076-82. PubMed ID: 17545373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.